Latest filing published 13 Jan 2025 for Akari Therapeutics Plc, €237.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -86.3%Entry US$6.13 · Close at T+365 US$0.84
- -41.3%Entry US$2.40 · Close at T+365 US$1.41
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Torsten Hombeck: trading record in brief
Torsten Hombeck is a declared insider at 2 companies; the most frequent names are Aspira Women's Health Inc. and Akari Therapeutics PLC. The record holds 4 filings, for trades running from 24 July 2023 to 10 January 2025.
Every open-market trade on record is a purchase: 2 purchases worth €12k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants.
On 13 January 2025 came the latest disclosure, a share grant for €237 in Akari Therapeutics PLC. The last insider purchase was made public on 12 September 2023, 1,155 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Torsten Hombeck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200 shares@ US$1.22100.0% of flowAmerican Depository Shares representing Ordinary SharesSEC:0000950170-25-004577:0
- 30,000 shares0Common StockSEC:0001983682-23-000005:0
- 2,246 shares@ US$4.3076.9% of flowCommon StockSEC:0001983682-23-000004:0Canonical exit: 7 Dec 2023 (T+90)
- 754 shares@ US$3.9823.1% of flowCommon stockSEC:0001983682-23-000002:0Canonical exit: 22 Oct 2023 (T+90)
4 of 4 declarations
